106
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Trivial or Troublesome: Experience with Coronary Heart Disease Medication from the Patient’s Perspective

, & ORCID Icon
Pages 411-424 | Published online: 27 Feb 2020

References

  • Bhatnagar P, Wickramasinghe K, Wilkins E, Townsend N. Trends in the epidemiology of cardiovascular disease in the UK. Heart. 2016;102:1945–1952. doi:10.1136/heartjnl-2016-309573
  • Socialstyrelsen. Myocardial Infarctions in Sweden 1994-2014; 2015.
  • Roth GA, Forouzanfar MH, Moran AE, et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med. 2015;372(14):1333–1341. doi:10.1056/NEJMoa1406656
  • Piepoli MF, Corra U, Adamopoulos S, et al. Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery: a policy statement from the cardiac rehabilitation section of the European Association for Cardiovascular Prevention & Rehabilitation. Endorsed by the committee for practice guidelines of the European Society of Cardiology. Eur J Prev Cardiol. 2014;21(6):664–681. doi:10.1177/2047487312449597
  • Karner A, Goransson A, Bergdahl B. Patients’ conceptions of coronary heart disease–a phenomenographic analysis. Scand J Caring Sci. 2003;17(1):43–50. doi:10.1046/j.1471-6712.2003.00113.x
  • Perk J, Hambraeus K, Burell G, Carlsson R, Johansson P, Lisspers J. Study of patient information after percutaneous coronary intervention (SPICI): should prevention programmes become more effective? EuroIntervention. 2015;10(11):e1–7. doi:10.4244/EIJV10I11A223
  • Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–2381. doi:10.1093/eurheartj/ehw106
  • Kramer JM, Hammill B, Anstrom KJ, et al. National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance. Am Heart J. 2006;152(3):454e451–458. doi:10.1016/j.ahj.2006.02.030
  • Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med. 2012;125(9):882–887.e881. doi:10.1016/j.amjmed.2011.12.013
  • Libungan B, Stensdotter L, Hjalmarson A, et al. Secondary prevention in coronary artery disease. Achieved goals and possibilities for improvements. Int J Cardiol. 2012;161(1):18–24. doi:10.1016/j.ijcard.2011.04.025
  • Hambraeus K, Lindhagen L, Tyden P, Lindahl B, Lagerqvist B. Target-attainment rates of low-density lipoprotein cholesterol using lipid-lowering drugs one year after acute myocardial infarction in sweden. Am J Cardiol. 2014;113(1):17–22. doi:10.1016/j.amjcard.2013.09.007
  • Ho PM, Magid DJ, Shetterly SM, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008;155(4):772–779. doi:10.1016/j.ahj.2007.12.011
  • Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006;166(17):1842–1847. doi:10.1001/archinte.166.17.1842
  • Jackevicius CA, Li P, Tu JV. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation. 2008;117(8):1028–1036. doi:10.1161/CIRCULATIONAHA.107.706820
  • Wroe AL. Intentional and unintentional nonadherence: a study of decision making. J Behav Med. 2002;25(4):355–372. doi:10.1023/A:1015866415552
  • Molloy GJ, Messerli-Burgy N, Hutton G, Wikman A, Perkins-Porras L, Steptoe A. Intentional and unintentional non-adherence to medications following an acute coronary syndrome: a longitudinal study. J Psychosom Res. 2014;76(5):430–432. doi:10.1016/j.jpsychores.2014.02.007
  • Pakpour AH, Gellert P, Asefzadeh S, Updegraff JA, Molloy GJ, Sniehotta FF. Intention and planning predicting medication adherence following coronary artery bypass graft surgery. J Psychosom Res. 2014;77(4):287–295. doi:10.1016/j.jpsychores.2014.07.001
  • Gehi AK, Ali S, Na B, Whooley MA. Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Arch Intern Med. 2007;167(16):1798–1803. doi:10.1001/archinte.167.16.1798
  • Gehi A, Haas D, Pipkin S, Whooley MA. Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med. 2005;165(21):2508–2513. doi:10.1001/archinte.165.21.2508
  • Sabate M. Adherence to Long-Term Therapies - Evidence for Action. Geneva: World Health Organization; 2003.
  • Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47(6):555–567. doi:10.1016/S0022-3999(99)00057-4
  • Allen LaPointe NM, Ou FS, Calvert SB, et al. Association between patient beliefs and medication adherence following hospitalization for acute coronary syndrome. Am Heart J. 2011;161(5):855–863. doi:10.1016/j.ahj.2011.02.009
  • Clifford S, Barber N, Horne R. Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the necessity-concerns framework. J Psychosom Res. 2008;64(1):41–46. doi:10.1016/j.jpsychores.2007.05.004
  • Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the necessity-concerns framework. PLoS One. 2013;8(12):e80633. doi:10.1371/journal.pone.0080633
  • Unni E, Shiyanbola OO, Farris KB. Change in medication adherence and beliefs in medicines over time in older adults. Glob J Health Sci. 2015;8(5):39–47. doi:10.5539/gjhs.v8n5p39
  • Sirey JA, Greenfield A, Weinberger MI, Bruce ML. Medication beliefs and self-reported adherence among community-dwelling older adults. Clin Ther. 2013;35(2):153–160. doi:10.1016/j.clinthera.2013.01.001
  • Gadkari AS, McHorney CA. Unintentional non-adherence to chronic prescription medications: how unintentional is it really? BMC Health Serv Res. 2012;12:98. doi:10.1186/1472-6963-12-98
  • Berglund E, Lytsy P, Westerling R. Adherence to and beliefs in lipid-lowering medical treatments: a structural equation modeling approach including the necessity-concern framework. Patient Educ Couns. 2013;91(1):105–112. doi:10.1016/j.pec.2012.11.001
  • Unni EJ, Farris KB. Unintentional non-adherence and belief in medicines in older adults. Patient Educ Couns. 2011;83(2):265–268. doi:10.1016/j.pec.2010.05.006
  • Byrne M, Walsh J, Murphy AW. Secondary prevention of coronary heart disease: patient beliefs and health-related behaviour. J Psychosom Res. 2005;58(5):403–415. doi:10.1016/j.jpsychores.2004.11.010
  • Horne R, Parham R, Driscoll R, Robinson A. Patients’ attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease. Inflamm Bowel Dis. 2009;15(6):837–844. doi:10.1002/ibd.20846
  • Tibaldi G, Clatworthy J, Torchio E, Argentero P, Munizza C, Horne R. The utility of the necessity–concerns framework in explaining treatment non-adherence in four chronic illness groups in Italy. Chronic Illn. 2009;5(2):129–133. doi:10.1177/1742395309102888
  • Kim SB, Kim KO, Jang BI, et al. Patients’ beliefs and attitudes about their treatment for inflammatory bowel disease in Korea. J Gastroenterol Hepatol. 2016;31(3):575–580. doi:10.1111/jgh.2016.31.issue-3
  • Allen LaPointe NM, Ou FS, Calvert SB, et al. Changes in beliefs about medications during long-term care for ischemic heart disease. Am Heart J. 2010;159(4):561–569. doi:10.1016/j.ahj.2009.12.025
  • Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119(23):3028–3035. doi:10.1161/CIRCULATIONAHA.108.768986
  • Krska J, Morecroft CW, Poole H, Rowe PH. Issues potentially affecting quality of life arising from long-term medicines use: a qualitative study. Int J Clin Pharm. 2013;35(6):1161–1169. doi:10.1007/s11096-013-9841-5
  • Attebring MF, Herlitz J, Ekman I. Intrusion and confusion–the impact of medication and health professionals after acute myocardial infarction. Eur J Cardiovasc Nurs. 2005;4(2):153–159. doi:10.1016/j.ejcnurse.2005.02.001
  • Roebuck A, Furze G, Thompson DR. Health-related quality of life after myocardial infarction: an interview study. J Adv Nurs. 2001;34(6):787–794. doi:10.1046/j.1365-2648.2001.01809.x
  • Lehane E, McCarthy G, Collender V, Deasy A. Medication-taking for coronary artery disease - patients’ perspectives. Eur J Cardiovasc Nurs. 2008;7(2):133–139. doi:10.1016/j.ejcnurse.2007.08.003
  • Rashid MA, Edwards D, Walter FM, Mant J. Medication taking in coronary artery disease: a systematic review and qualitative synthesis. Ann Fam Med. 2014;12(3):224–232. doi:10.1370/afm.1620
  • Johansson Östbring M, Eriksson T, Petersson G, Hellstrom L. Motivational interviewing and medication review in coronary artery disease (MIMeRiC) - study protocol for a randomized, controlled trial investigating effects on clinical outcomes, adherence and quality of life. J Med Internet Res. 2018;7(2):e57.
  • Johansson Östbring M, Eriksson T, Petersson G, Hellström L. Development of an adherence intervention and a protocol for the process evaluation - Motivational interviewing and medication review in coronary heart disease (MIMeRiC). J Med Internet Res. 2018;7(2):e57.
  • Elo S, Kyngas H. The qualitative content analysis process. J Adv Nurs. 2008;62(1):107–115. doi:10.1111/j.1365-2648.2007.04569.x
  • Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today. 2004;24(2):105–112. doi:10.1016/j.nedt.2003.10.001
  • Svensson S, Kjellgren KI, Ahlner J, Saljo R. Reasons for adherence with antihypertensive medication. Int J Cardiol. 2000;76(2–3):157–163. doi:10.1016/S0167-5273(00)00374-0
  • Moen J, Bohm A, Tillenius T, Antonov K, Nilsson JL, Ring L. “I don’t know how many of these [medicines] are necessary.” - a focus group study among elderly users of multiple medicines. Patient Educ Couns. 2009;74(2):135–141. doi:10.1016/j.pec.2008.08.019
  • van der Laan DM, Elders PJM, Boons C, Nijpels G, Krska J, Hugtenburg JG. The impact of cardiovascular medication use on patients’ daily lives: a cross-sectional study. Int J Clin Pharm. 2018;40(2):412–420. doi:10.1007/s11096-018-0601-4
  • Pettersen TR, Fridlund B, Bendz B, et al. Challenges adhering to a medication regimen following first-time percutaneous coronary intervention: A patient perspective. Int J Nurs Stud. 2018;88:16–24. doi:10.1016/j.ijnurstu.2018.07.013
  • Carter SR, Moles R, White L, Chen TF. Medication information seeking behavior of patients who use multiple medicines: how does it affect adherence?. Patient Educ Couns. 2013;92(1):74–80. doi:10.1016/j.pec.2013.01.019
  • van Geffen EC, Philbert D, van Boheemen C, van Dijk L, Bos MB, Bouvy ML. Patients’ satisfaction with information and experiences with counseling on cardiovascular medication received at the pharmacy. Patient Educ Couns. 2011;83(3):303–309. doi:10.1016/j.pec.2011.04.004
  • Stevenson FA, Cox K, Britten N, Dundar Y. A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance. Health Expect. 2004;7(3):235–245. doi:10.1111/hex.2004.7.issue-3
  • Kohlmann S, Kilbert MS, Ziegler K, Schulz KH. Supportive care needs in patients with cardiovascular disorders. Patient Educ Couns. 2013;91(3):378–384. doi:10.1016/j.pec.2013.01.002
  • Barber N, Parsons J, Clifford S, Darracott R, Horne R. Patients’ problems with new medication for chronic conditions. Qual Saf Health Care. 2004;13(3):172–175. doi:10.1136/qshc.2003.005926
  • Gordon K, Smith F, Dhillon S. Effective chronic disease management: patients’ perspectives on medication-related problems. Patient Educ Couns. 2007;65(3):407–415. doi:10.1016/j.pec.2006.09.012
  • Pound P, Britten N, Morgan M, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005;61(1):133–155. doi:10.1016/j.socscimed.2004.11.063
  • Foot H, La Caze A, Gujral G, Cottrell N. The necessity-concerns framework predicts adherence to medication in multiple illness conditions: A meta-analysis. Patient Educ Couns. 2016;99(5):706–717. doi:10.1016/j.pec.2015.11.004
  • Granas AG, Bates I. Patients’ understanding and management of their illnesses and prescribed medicines–a descriptive study. Pharm World Sci. 2005;27(4):321–328. doi:10.1007/s11096-005-5999-9
  • Reach G. Role of habit in adherence to medical treatment. Diabet Med. 2005;22(4):415–420. doi:10.1111/dme.2005.22.issue-4
  • Alison Phillips L, Leventhal H, Leventhal EA. Assessing theoretical predictors of long-term medication adherence: patients’ treatment-related beliefs, experiential feedback and habit development. Psychol Health. 2013;28(10):1135–1151. doi:10.1080/08870446.2013.793798
  • Shoemaker SJ. Ramalho de Oliveira D. Understanding the meaning of medications for patients: the medication experience. Pharm World Sci. 2008;30(1):86–91. doi:10.1007/s11096-007-9148-5
  • Felzmann H. Adherence, compliance, and concordance: an ethical perspective. Nurse Prescribing. 2012;10(8):406–411.
  • Bell JS, Airaksinen MS, Lyles A, Chen TF, Aslani P. Concordance is not synonymous with compliance or adherence. Br J Clin Pharmacol. 2007;64(5):710–711. (). doi:10.1111/j.1365-2125.2007.02971_1.x
  • Mullen PD. Compliance becomes concordance. BMJ. 1997;314(7082):691–692. doi:10.1136/bmj.314.7082.691
  • Barry MJ, Edgman-Levitan S. Shared decision making–pinnacle of patient-centered care. N Engl J Med. 2012;366(9):780–781. doi:10.1056/NEJMp1109283
  • Ekman I, Swedberg K, Taft C, et al. Person-centered care–ready for prime time. Eur J Cardiovasc Nurs. 2011;10(4):248–251. doi:10.1016/j.ejcnurse.2011.06.008
  • Barnett NL, Sanghani P. A coaching approach to improving concordance. Int J Pharm Pract. 2013;21(4):270–272. doi:10.1111/ijpp.2013.21.issue-4
  • Elo S, Kääriäinen M, Kanste O, Pölkki T, Utriainen K, Kyngäs H. Qualitative content analysis: a focus on trustworthiness. SAGE Open. 2014;4(1):2158244014522633. doi:10.1177/2158244014522633
  • Shoemaker SJ, Ramalho de Oliveira D, Alves M, Ekstrand M. The medication experience: preliminary evidence of its value for patient education and counseling on chronic medications. Patient Educ Couns. 2011;83(3):443–450. doi:10.1016/j.pec.2011.02.007
  • Fors A, Swedberg K, Ulin K, Wolf A, Ekman I. Effects of person-centred care after an event of acute coronary syndrome: two-year follow-up of a randomised controlled trial. Int J Cardiol. 2017;249:42–47. doi:10.1016/j.ijcard.2017.08.069